Our findings, identifying a miR-145-5p/c-MYC/EGFR/MUC1/OCT4 network, provided further evidence demonstrating that the altered activity of non-coding RNAs either as loss of tumor suppressor activity or gain of oncogenic functions might play in the chemoresistance of metastatic lesions. This evidence concerns the gene MUC1 and neoplasm.